-
SPDR S&P Biotech ETF (XBI) options active option volume of 120K contracts
-
Trump: Will Be Reducing Drug Prices By 1400%-1500%
-
White House: Trump took action on pharma Thursday, sent letters to CEOs
-
Trump: will announce something on pharmaceuticals very soon
-
FDA to issue new vouchers to drug developers to shorten review time
-
Biotech stocks Q1 earnings review
-
SPDR S&P Biotech ETF (XBI) options active amid FDA leadership headlines
-
SPDR S&P Biotech ETF (XBI) puts more active than calls amid price pull back
-
SPDR S&P Biotech ETF (XBI) call put ratio 1 call to 1.2 puts as share price down 4.9%
-
Cantor Fitzgerald says 15% of biotech companies down 40% or more
-
RBC's biotech survey shows investors more bearish vs. last time

